Spots Global Cancer Trial Database for doxorubicin hydrochloride liposome injection
Every month we try and update this database with for doxorubicin hydrochloride liposome injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial | NCT04872985 | Breast Cancer Hormone-recepto... | Pyrotinib Epirubicin Doxorubicin Hyd... Cyclophosphamid... Docetaxel Nab paclitaxel Placebo | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | NCT02260544 | Ovarian Epithel... | Doxorubicin Hyd... | 18 Years - 60 Years | Dr. Reddy's Laboratories Limited | |
| A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | NCT04460820 | Bioequivalence | Doxorubicin Hyd... | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients | NCT05273944 | Breast Cancer Ovarian Cancer | Doxorubicin Hyd... | 18 Years - 75 Years | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | |
| Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma | NCT05457829 | Rhabdomyosarcom... | Doxorubicin Hyd... Temozolomide+Ir... | 6 Months - 18 Years | Sun Yat-sen University | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | NCT02260544 | Ovarian Epithel... | Doxorubicin Hyd... | 18 Years - 60 Years | Dr. Reddy's Laboratories Limited | |
| A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer | NCT03017404 | Breast Cancer | Doxorubicin Hyd... Cyclophosphamid... docetaxel | 18 Years - 70 Years | Hebei Medical University Fourth Hospital | |
| A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer | NCT03017404 | Breast Cancer | Doxorubicin Hyd... Cyclophosphamid... docetaxel | 18 Years - 70 Years | Hebei Medical University Fourth Hospital | |
| Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo | NCT05354076 | Advanced Malign... | doxorubicin hyd... | 18 Years - 70 Years | Fudan University | |
| Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma | NCT05457829 | Rhabdomyosarcom... | Doxorubicin Hyd... Temozolomide+Ir... | 6 Months - 18 Years | Sun Yat-sen University | |
| A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer | NCT03017404 | Breast Cancer | Doxorubicin Hyd... Cyclophosphamid... docetaxel | 18 Years - 70 Years | Hebei Medical University Fourth Hospital | |
| Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer | NCT06098599 | Advanced Breast... | Doxorubicin hyd... | 18 Years - 75 Years | Luye Pharma Group Ltd. | |
| A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer. | NCT03681548 | Ovarian Cancer ... | Doxorubicin Hyd... | 18 Years - 65 Years | Ayana Pharma Ltd., | |
| Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | NCT00632827 | Peripheral T-Ce... | Gemcitabine Navelbine Doxorubicin Hyd... Granulocyte-col... Pegfilgrastim Cyclophosphamid... Vincristine Leucovorin Methotrexate Doxorubicin Hyd... Cytarabine Etoposide Carmustine Denileukin dift... | 18 Years - 70 Years | University of California, San Francisco | |
| R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse | NCT05257018 | Diffuse Large B... | R-CDOP+intrathe... | 18 Years - 75 Years | Fudan University | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients | NCT05273944 | Breast Cancer Ovarian Cancer | Doxorubicin Hyd... | 18 Years - 75 Years | Shenzhen Kangzhe Pharmaceutical Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
